The search for effective HIV vaccines

Article Abstract:

A team of scientists in February 2003 representing the biotechnology company VaxGen announced the results of the first phase 3 trial to test the efficiency of a vaccine against the human immunodeficiency virus (HIV). Although experts have not given up the ultimate goal of a preventive vaccine, they are hopeful that a therapeutic vaccine would help stem the devastating series of disease, disability, and death from AIDS.

United States, Clinical trials, Dosage and administration, AIDS vaccines

---

Interactions among drugs for HIV and opportunistic infections

Article Abstract:

HIV patients often take drugs for the HIV infection, drugs to prevent opportunistic infections, and other drugs for any other health condition they may have. This may result in drug interactions that may reduce the effectiveness of a drug. A list of web sites with information about drug interactions is included.

Analysis, Drug interactions

---

Antiretroviral therapy for previously treated patients

Article Abstract:

HIV patients who have already received one class of AIDS drug should be treated with another class if they do not respond to the first one. Those who have been treated with two or more may need to take four or five drugs.

Editorial

Similar abstracts:

• Abstracts: Trends in prescriptions for highly active antiretroviral therapy in four New York City HIV clinics. Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy
• Abstracts: Trends in prescriptions for highly active antiretroviral therapy in four New York City HIV clinics. part 2 Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy
• Abstracts: Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. Cognitive function in HIV-1-infected drug users
• Abstracts: The case for routine childhood vaccination against hepatitis A. Chronic hepatitis C virus infection
• Abstracts: Goserelin - another LH-RH analog for prostate cancer. St. John's wort. PC Spes

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.